MIRASOL trial and DESTINY-PanTumor02 Trial Overview

Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong

Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.

December 21st 2023

Research Unveils UGT2B17 as Key Prognostic Marker in CLL

Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.

Listen

CLL on a keyboard | Image Credit: momius - stock.adobe.com

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

UGT2B17, a metabolic enzyme known for regulating various endogenous molecules, has been identified to have heightened expression in the B cells of patients who have chronic lymphocytic leukemia (CLL).

November 30th 2023

Patients With DMD Receiving Eteplirsen Show Prolonged Survival, Study Finds

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

Duchenne medicial concept | Image credit: hafakot - stock.adobe.com

When Uncontrolled Diabetes and a Fungus Meet: Emergency Treatment of Rhino-Orbital-Cerebral Mucormycosis

The study provides evidence of survival benefits among patients with Duchenne muscular dystrophy (DMD) receiving eteplirsen compared with the natural history of the condition.

Mucormycosis mold fungus | Image Credit: © wladimir1804 - stock.adobe.com

Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD

JAMA used a case report of rhino-orbital-cerebral mucormycosis in a patient with uncontrolled diabetes to demonstrate correct and incorrect treatment choices.

Related Content

Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong

Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.

December 21st 2023

Research Unveils UGT2B17 as Key Prognostic Marker in CLL

Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.

Listen

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

November 30th 2023

Patients With DMD Receiving Eteplirsen Show Prolonged Survival, Study Finds

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

When Uncontrolled Diabetes and a Fungus Meet: Emergency Treatment of Rhino-Orbital-Cerebral Mucormycosis

The study provides evidence of survival benefits among patients with Duchenne muscular dystrophy (DMD) receiving eteplirsen compared with the natural history of the condition.